The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Ethoxy-2-aminoethoxyl-O-(alpha-L-idopyranosyl Uronic Acid-alpha(1->4)-alpha-L-idopyranosyl Uronic Acid-alpha(1->4))-alpha-L-idopyranoside Uronic Acid ID: ALA5082502
Chembl Id: CHEMBL5082502
PubChem CID: 166628214
Max Phase: Preclinical
Molecular Formula: C22H35NO20
Molecular Weight: 633.51
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: NCCOCCO[C@@H]1O[C@@H](C(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](O[C@@H]3O[C@@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O
Standard InChI: InChI=1S/C22H35NO20/c23-1-2-37-3-4-38-20-10(29)7(26)12(15(42-20)18(33)34)40-22-11(30)8(27)13(16(43-22)19(35)36)39-21-9(28)5(24)6(25)14(41-21)17(31)32/h5-16,20-22,24-30H,1-4,23H2,(H,31,32)(H,33,34)(H,35,36)/t5-,6-,7+,8+,9+,10+,11+,12-,13-,14+,15+,16+,20+,21+,22+/m0/s1
Standard InChI Key: NMWXIQVXAJOCSZ-XLWQTZEDSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 633.51Molecular Weight (Monoisotopic): 633.1752AlogP: -7.30#Rotatable Bonds: 13Polar Surface Area: 344.14Molecular Species: ZWITTERIONHBA: 18HBD: 11#RO5 Violations: 3HBA (Lipinski): 21HBD (Lipinski): 12#RO5 Violations (Lipinski): 3CX Acidic pKa: 2.62CX Basic pKa: 9.44CX LogP: -8.36CX LogD: -14.92Aromatic Rings: ┄Heavy Atoms: 43QED Weighted: 0.08Np Likeness Score: 0.92
References 1. Shanthamurthy CD, Leviatan Ben-Arye S, Kumar NV, Yehuda S, Amon R, Woods RJ, Padler-Karavani V, Kikkeri R.. (2021) Heparan Sulfate Mimetics Differentially Affect Homologous Chemokines and Attenuate Cancer Development., 64 (6.0): [PMID:33683903 ] [10.1021/acs.jmedchem.0c01800 ]